588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Monalizumab Acute Myeloid Leukemia	Istituto Clinico Humanitas	P2	CCC (53)
Pacritinib Acute Myeloid Leukemia	University of Washington	P2	CCC (53)
Ptcy Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P2	CCC (53)
Pyronaridine Tetraphosphate Acute Myeloid Leukemia	Armaceutica, Inc.	P2	CCC (53)
Qhrd107 Acute Myeloid Leukemia	Changzhou Qianhong Bio-pharma Co., Ltd.	P2	CCC (53)
Vah Acute Myeloid Leukemia	Dongguan People's Hospital	P2	CCC (53)
Zemestosita Acute Myeloid Leukemia	Liping Dou	P2	CCC (53)
18f-flt Acute Myeloid Leukemia	University of Oklahoma	P2	CCC (52)
Avastinib Acute Myeloid Leukemia	Ruijin Hospital	P2/3	CCC (52)
Bemcentinib Acute Myeloid Leukemia	BerGenBio ASA	P2	CCC (52)
Bl-M11D1 Acute Myeloid Leukemia	Sichuan Baili Pharmaceutical Co., Ltd.	P2/3	CCC (52)
Docetaxel Acute Myeloid Leukemia	Syndax Pharmaceuticals	P2	CCC (52)
Midazolam Acute Myeloid Leukemia	Novartis Pharmaceuticals	P1/2	CCC (52)
Nepenthe Acute Myeloid Leukemia	Peking University People's Hospital	P3	CCC (52)
Pomalidomide Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (52)
Talazoparib Acute Myeloid Leukemia	German Cancer Research Center	P1/2	CCC (52)
Tocilizumab Acute Myeloid Leukemia	Nantes University Hospital	P2	CCC (52)
Everolimus Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P1/2	CCC (51)
Ficlatuzumab Acute Myeloid Leukemia	AVEO Pharmaceuticals, Inc.	P2	CCC (51)
Hpc, Cord Blood Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Itacitinib Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (51)
Vedolizumab Acute Myeloid Leukemia	City of Hope Medical Center	P3	CCC (51)
ze46-0134 Acute Myeloid Leukemia	Lomond Therapeutics Holdings, Inc.	P1/2	CCC (51)
Allogeneic Cd8+ Leukemia-Associated Antigens Specific T Cells Nexi-001 Acute Myeloid Leukemia	City of Hope Medical Center	P1/2	CCC (50)
Atezolizumab Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CCC (50)
Calaspargase Pegol Acute Myeloid Leukemia	Children's Oncology Group	P2	CCC (50)
Cobimetinib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CCC (50)
Dexrazoxane Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CCC (50)
Dna, D(3'-Amino-3'-Deoxy-P-Thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-Hydroxy-3-((1-Oxohexadecyl)Amino)Propyl) Hydrogen Phosphorothioate) Acute Myeloid Leukemia	Douglas Tremblay	P2	CCC (50)
Fludeoxyglucose Acute Myeloid Leukemia	Children's Oncology Group	P3	CCC (50)
Hmpl-306 Acute Myeloid Leukemia	Hutchmed	P3	CCC (50)
Metformin Acute Myeloid Leukemia	Wake Forest University Health Sciences	P2	CCC (50)
NK-92 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (50)
Olaparib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (50)
Palifermin Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (50)
Recombinant Human Thrombopoietin Acute Myeloid Leukemia	Huihan Wang	P3	CCC (50)
RVU120 Acute Myeloid Leukemia	Ryvu Therapeutics SA	P2	CCC (50)
Sonrotoclax Acute Myeloid Leukemia	Ruijin Hospital	P2	CCC (50)
Veliparib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (50)
Vincristine Sulfate Acute Myeloid Leukemia	Children's Oncology Group	P2	CCC (50)
Xylitol Acute Myeloid Leukemia	Children's Oncology Group	P3	CCC (50)
Anti-Cd33 Car T-Cells Acute Myeloid Leukemia	Zhejiang University	P1/2	CCC (49)
cll1 car t-cells Acute Myeloid Leukemia	Tongji Hospital	P1/2	CCC (49)
Rimiducid Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	CCC (49)
Treg Cells Acute Myeloid Leukemia	Antonio Pierini	P2	CCC (49)
8-chloroadenosine Acute Myeloid Leukemia	City of Hope Medical Center	P1/2	CCC (48)
Adaptnk Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1/2	CCC (48)
Allogenic Nk Cells Acute Myeloid Leukemia	Xuzhou Medical University	P1/2	CCC (48)
Apamistamab-B10-Astatine At-211 Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Apg 115 Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P1/2	CCC (48)

Showing 151 to 200 of 588 assets

PreviousPage 4 of 12Next